Skip to content

Early Occupational Therapy in Mechanical Ventilated Patients With Covid-19

Early Occupational Therapy in Mechanical Ventilated Patients With Covid-19: Multicentre Pilot Randomized Clinical Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04904497
Enrollment
60
Registered
2021-05-27
Start date
2021-04-01
Completion date
2021-12-31
Last updated
2021-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Covid19, Critical Illness, Impairment, Cognitive, Impairment, Coordination

Brief summary

This study evaluates the feasibility of an early occupational therapy (OT) protocol in critical adult patients requiring mechanical ventilation with Covid-19.

Detailed description

A randomized clinical trial with an experimental-control will be implemented, considering the prospective multicenter group, with parallel groups, in a 1:1 ratio, in 3 Chilean hospitals. A control group will has a standard analgesia, sedation, delirium and mobilization (ASDM) measures or an intervention group will have early OT plus ASDM. The intervention group will receive 20 OT sessions, which considers a predefined protocol of actions according to the patient's condition

Interventions

Occupational therapists will implement the following activities: * Polysensory stimulation: external stimulation for increasing the level of alertness. It will be implemented with SAS 2 one session each 24 h. * Cognitive stimulation: bundle of exercises for activating mental functions, i.e: alertness, visual perception, memory, calculus, problem solving, praxis, language. Patients with SAS 3, 4 and 5. In SAS \<2, 6\> environmental orientation will be considered * Basic activities of daily living (BADLs): promotion of independence that initially practice hygiene, personal grooming. Patients with SAS 3, 4 and 5 * Motor function Stimulation: exercises to keep the patient's upper extremities active and functional. Patients with SAS with 3,4 and 5. Patients with SAS 1 and 2 will use adaptations to prevent edema and bedsores on vulnerable body areas * Education: trained family members and health staff about the intervention process

Sponsors

Hospital Base Valdivia
CollaboratorUNKNOWN
Hospital Santiago Oriente - Dr. Luis Tisné Brousse
CollaboratorUNKNOWN
University of Chile
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Caregiver, Investigator, Outcomes Assessor)

Masking description

In this study, researchers, recruiters, evaluators, control group team and data analyst will be masked. These teams will not have contact with the interventionists of the experimental group. Evaluators who have contact with the patients of both groups, they will be professionals from other medical units, who do not know the ICU team, and will only be able to maintain their dialog, according to the guideline of each evaluation. It is not possible to mask the treating occupational therapist and patient receiving OT.

Intervention model description

A control group (standard ASDM measures) or an intervention group (early and intensive occupational therapy + ASDM) will be randomized. The intervention group will receive 20 occupational therapy sessions. The interventions will be organized on the basis of i) level of sedation, ii) presence or absence of delirium (according to CAM ICU +/- (Confusion Assessment Method Intensive Care Unit)), iii) movement with or without gravity (cut-off point 3 points in elbow flexion movement in Medical Research Council(MRC)). The areas of intervention implemented by occupational therapist will be: i) Polysensory stimulation, ii) Cognitive stimulation, iii) Basic activities of daily living, iv) Motor function stimulation, v) Education

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Age equal to or greater than 18 years. * Need for hospitalization in ICU. * At least 12 h of invasive mechanical ventilation * Informed consent signed by legal representative and / or patient. * Positive covid-19 diagnosis

Exclusion criteria

* Known cognitive impairment before admission with short IQCODE (Informant Questionnaire on Cognitive Decline in the Elderly) Scores\> 3.3 were excluded. * Previous functional impairment, FAQ (Functional Activities Questionnaire) defined as \> 6 points. * Severe communication disorder and cultural limitation of language (language different from Spanish) * Patient with limited therapeutic proportionality. * Neurocritical patients (moderate-severe Traumatic Brain Injury / stroke of some kind / among others) * Spinal injury or unstable fractures that limit mobilization

Design outcomes

Primary

MeasureTime frameDescription
Functional independence at hospital dischargeDay 28 (+/- 3 days) from beginning of mechanical ventilationThe FIM (Functional independence measure) instrument will be applied by evaluator team. This scale shows that higher score is better, which will be compared between control and experimental group

Secondary

MeasureTime frameDescription
Coma-free daysDefined as the number of days in the first 14 days with the SAS.SAS (Sedation-Agitation Scale) instrument will be applied once a day by evaluator. If SAS 1-2: coma day
Delirium-coma free daysDefined as the number of days in the first 14 days with the SAS and CAM-ICUSAS and CAM-ICU instruments will be applied once a day by evaluator. Every day without coma or delirium its an delirium-coma free day
Functional independence at hospital dischargeDay 90 (+/- 7 days) from beginning of mechanical ventilationThe FIM (Functional independence measure) instrument will be applied by evaluator team. This scale shows that higher score is better, which will be compared between control and experimental group
Delirium-free daysDefined as the number of days in the first 14 days with the CAM-ICU instrument negative and non-coma day.CAM-ICU (Confusion Assessment Method Intensive Care Unit) instrument will be applied once a day by evaluatorhigher score is better, which will be compared between control and experimental group
Motor status of patientsDay 28 (+/- 3 days) from beginning of mechanical ventilationGrip strength (motor status) with dynamometer will be applied by evaluator. This scale shows that higher score is better, which will be compared between control and experimental group
Quality of life of patientsDay 90 (+/- 7 days) from beginning of mechanical ventilationEQ-5D-5L (Euro Qol 5 dimensions 5 level) will be applied by evaluator. It will be considered a cut-off point in the Chilean population
Characterization of occupational therapy interventionsDays of patient hospitalizationNumber of sessions implemented, number of sessions suspended
Cognitive status of patientsDay 28 (+/- 3 days) from beginning of mechanical ventilation and day 90 (+/- 7 days)after hospital dischargeMoCA (Montreal Cognitive Assessment) instrument (cognitive status).This scale shows that higher score is better, which will be compared between control and experimental group

Countries

Chile

Contacts

Primary ContactEduardo Tobar, MD
etobar@hcuch.cl+56229786009
Backup ContactEvelyn Alvarez, Master
evalvarez@uchile.cl+56229786009

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026